Published Date: 05 Oct 2025
Patients with cancer whose credit scores decline after their diagnosis face a significantly higher risk of mortality, providing the first objective data linking financial health to physical survival.
Read Full NewsNeuroblastoma is a type of cancer that affects the sympathetic nervous system in young children and is often difficult to treat, especially when the tumor cells carry multiple copies of the MYCN gene.
One in five women with breast or cervical cancer in low- and middle-income countries (LMICs) are diagnosed at an early stage, compared with more than one in three in high-income countries (HICs), new research suggests. For ...
1.
Insurance Claim Denials for Preventive Care More Common in At-Risk Patients
2.
Gene therapy and chemotherapy may be combined in novel ways to treat bone cancer.
3.
In a recent study, Kencur ginger's anti-cancer properties were discovered.
4.
Certain Oral Bacteria May Be a Risk Factor for Head and Neck Cancer
5.
Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC
1.
Beyond the Battle: Navigating Life After Cancer
2.
Revolutionizing Cancer Treatment: How Adoptive Cell Therapy is Overcoming Tumor Immune Evasion
3.
The Importance of Maintaining Normal Calcium Levels in Your Body
4.
The Statistical Imperative: Navigating Trends, Precision, and Innovation in Gynecologic Oncology 2025
5.
A Visual Journey Through Penile Cancer: Examining the Impact of Photos
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
3.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation